Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN) will present virtually at the 10th Annual SVB Leerink Healthcare Conference from February 22-26, 2021. Tony J. Hunt, the President and CEO, is scheduled to participate in a fireside chat on February 26 at 12:00 p.m. EST. Investors can access a live webcast and replay through the Company’s Investor Relations website. Repligen specializes in bioprocessing technologies that enhance the manufacturing of biological drugs, catering mainly to biopharmaceutical developers globally.

WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 10th Annual SVB Leerink Healthcare conference being held February 22-26.  Tony J. Hunt, President and Chief Executive Officer, will participate in a fireside chat on Friday, February 26, at 12:00 p.m. EST.

A live webcast of the discussion will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Our primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

FAQ

When is Repligen's presentation at the SVB Leerink Healthcare Conference?

Repligen Corporation's presentation is scheduled for February 26, 2021.

Who will represent Repligen at the conference?

Tony J. Hunt, the President and CEO, will represent Repligen.

How can I watch Repligen's presentation?

You can watch the presentation live via the Investor Relations section on Repligen's website.

What is Repligen Corporation known for?

Repligen is known for its innovative bioprocessing technologies that improve drug manufacturing efficiency.

Where is Repligen Corporation headquartered?

Repligen Corporation is headquartered in Waltham, Massachusetts.